VanEck Biotech is trading at 2248.00 as of the 28th of December 2024; that is No Change since the beginning of the trading day. The etf's open price was 2248.0. VanEck Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of December 2024. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VanEck Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VanEck Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
VanEck Biotech ETF [BBH] is traded in Mexico and was established December 20, 2011. The fund is listed under Health category and is part of Market Vectors family. This fund currently have 534.3 M in assets under management (AUM). VanEck Biotech ETF is producing Year-To-Date (YTD) return of -19.01% with the current yeild of 0.33%, while the total return for the last 3 years was 31.88%.
Check VanEck Biotech Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in VanEck Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Global Markets Map Now
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Additional Information and Resources on Investing in VanEck Etf
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.